HIV prevention: integrating biomedical and behevioral interventions

Area of Science:

• Public Health
• Infectious Diseases
• Clinical Medicine

Background:

• Recent IAS-USA panel recommendations address critical aspects of HIV care and prevention.
• Many individuals with HIV in the U.S. are not fully engaged in care, leading to incomplete viral suppression and ongoing transmission.
• Effective HIV prevention strategies are crucial for moving patients through the HIV care continuum.

Purpose of the Study:

• To summarize recent IAS-USA recommendations for HIV prevention in clinical settings.
• To highlight key strategies for both HIV-infected individuals and those at risk of infection.
• To emphasize the importance of engaging patients in the HIV care continuum.

Main Methods:

• Summary of an IAS-USA continuing education webinar presented by Carlos del Rio, MD.
• Review of published recommendations from an IAS-USA panel.
• Focus on clinical care settings and patient engagement.

Main Results:

• Recommendations include HIV testing, antiretroviral therapy (ART) initiation, and adherence counseling for HIV-infected individuals.
• For those at risk, recommendations cover pre-exposure prophylaxis (PrEP), risk-reduction counseling, and post-exposure prophylaxis (PEP).
• Emphasis on strategies to improve patient engagement in the HIV care continuum for better viral suppression.

Conclusions:

• Adherence to updated HIV prevention guidelines is essential for clinical practice.
• Comprehensive strategies are needed to address the HIV care continuum and reduce transmission.
• Effective risk-reduction and adherence counseling are vital components of HIV management.